Fairvalue-Calculator Fairvalue-Calculator
EN DE

WeLeader Biomedical Co (7713) Fair Value & Analysis

Healthcare · TW · Market cap 3.2B TWD

Price71.00 TWD
Fair Value73.48 TWD
Upside+3.5%
Quality95/100
Evidence: High Range 36.01 TWD – 104.93 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

WeLeader Biomedical Co (7713) currently trades at 71.00 TWD, while our model-based Fair Value estimate is 73.48 TWD — implying the stock looks roughly 3.5% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic electronic luminescence immunoassay products, fully automatic modular biochemical immune assay products, TTA automated pre-processing products, POCT central laboratory products, and CCM fully automated track processing products. It serves research institutions, schools, hospitals, laboratories, and hospitals. The company was founded in 1992 and is headquartered in Kaohsiung, Taiwan.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is WeLeader Biomedical Co (7713) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 73.48 TWD versus a price of 71.00 TWD — about +3% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 7713?
Our 21-model fair value for WeLeader Biomedical Co is 73.48 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 71.00 TWD.
What is the quality score of 7713?
WeLeader Biomedical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.